Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2014 4
2015 1
2016 3
2017 4
2018 3
2019 3
2020 1
2021 5
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Related Articles by Review for PMID: 23091115

32 results

Results by year

Filters applied: . Clear all
Page 1
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.
Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, Shen L, Fan Y, Giri U, Tumula PK, Nilsson MB, Gudikote J, Tran H, Cardnell RJ, Bearss DJ, Warner SL, Foulks JM, Kanner SB, Gandhi V, Krett N, Rosen ST, Kim ES, Herbst RS, Blumenschein GR, Lee JJ, Lippman SM, Ang KK, Mills GB, Hong WK, Weinstein JN, Wistuba II, Coombes KR, Minna JD, Heymach JV. Byers LA, et al. Clin Cancer Res. 2013 Jan 1;19(1):279-90. doi: 10.1158/1078-0432.CCR-12-1558. Epub 2012 Oct 22. Clin Cancer Res. 2013. PMID: 23091115 Free PMC article.
EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer.
Tulchinsky E, Demidov O, Kriajevska M, Barlev NA, Imyanitov E. Tulchinsky E, et al. Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):29-39. doi: 10.1016/j.bbcan.2018.10.003. Epub 2018 Nov 10. Biochim Biophys Acta Rev Cancer. 2019. PMID: 30419315 Review.
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations.
Ahn MJ, Mendoza MJL, Pavlakis N, Kato T, Soo RA, Kim DW, Liam CK, Hsia TC, Lee CK, Reungwetwattana T, Geater S, Chan OSH, Prasongsook N, Solomon BJ, Nguyen TTH, Kozuki T, Yang JC, Wu YL, Mok TSK, Tan DS, Yatabe Y. Ahn MJ, et al. Clin Lung Cancer. 2022 Dec;23(8):670-685. doi: 10.1016/j.cllc.2022.07.012. Epub 2022 Aug 23. Clin Lung Cancer. 2022. PMID: 36151006 Free article. Review.
AXL kinase as a novel target for cancer therapy.
Wu X, Liu X, Koul S, Lee CY, Zhang Z, Halmos B. Wu X, et al. Oncotarget. 2014 Oct 30;5(20):9546-63. doi: 10.18632/oncotarget.2542. Oncotarget. 2014. PMID: 25337673 Free PMC article. Review.
32 results